No Picture
News

Jennifer Doudna spinout inks a Mammoth CRISPR deal with Vertex worth nearly $700M

When a company gets its start in gene editing pioneer Jennifer Doudna’s lab, it’s bound to make headlines. But three years in, the fanfare still hasn’t died down for Mammoth Biosciences. Now, the Brisbane, CA-based company is cheering on its first majo… […]

No Picture
News

Anitoa Receives FDA Registration and Class II Exempt Device Listing for its Maverick Line of Portable qPCR Instruments

SUNNYVALE, Calif.: SUNNYVALE, Calif., Oct. 26, 2021 /PRNewswire/ — Anitoa Systems, LLC., a Silicon Valley biotechnology company and market leader in rapid, portable molecular testing hardware, today announced its Maverick line of qPCR instruments have… […]

No Picture
News

Anixa Biosciences Announces Patient Dosing of its Investigational Vaccine Candidate in a First-of-its-Kind Preventative Breast Cancer Vaccine Study

SAN JOSE, Calif. and CLEVELAND: SAN JOSE, Calif. and CLEVELAND, Oct. 26, 2021 /PRNewswire/ — Anixa Biosciences, Inc. (NASDAQ: ANIX) ("Anixa") a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, … […]

No Picture
News

Vaxart Doses First Subject in Phase II COVID-19 Oral Tablet Vaccine Clinical Trial

SOUTH SAN FRANCISCO, Calif.: SOUTH SAN FRANCISCO, Calif., Oct. 26, 2021 /PRNewswire/ — Vaxart, Inc. (NASDAQ: VXRT) today announced that it has dosed the first subject in its Phase II COVID-19 oral tablet vaccine clinical trial, the only Phase II trial… […]